{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:07:08Z","timestamp":1720220828233},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.thromres.2017.05.034","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T05:15:39Z","timestamp":1496380539000},"page":"242-245","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Occult cancer detection in patients with hemostatic disorder and venous thromboembolism"],"prefix":"10.1016","volume":"163","author":[{"given":"Holleh","family":"Husseinzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2017.05.034_bb0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1172\/JCI113411","article-title":"Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo","volume":"81","author":"Karpatkin","year":"1988","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.034_bb0010","first-page":"467","article-title":"Von Willebrand factor interacts with malignant hematopoietic cell lines: evidence for the presence of specific binding sites and modification of von Willebrand factor structure and function","volume":"119","author":"Floyd","year":"1992","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.034_bb0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0038-1642691","article-title":"Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo","volume":"74","author":"Nierodzik","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2017.05.034_bb0020","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.271.10.5892","article-title":"Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow","volume":"271","author":"Felding-Habermann","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.034_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-2143(97)90182-7","article-title":"Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-Ib alpha with different functional properties","volume":"129","author":"Oleksowicz","year":"1997","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.034_bb0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V96.5.1789","article-title":"Immobilized platelets suport human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions","volume":"96","author":"McCarty","year":"2000","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.thromres.2017.05.034_bb0035","doi-asserted-by":"crossref","first-page":"21930","DOI":"10.1074\/jbc.M201630200","article-title":"Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions","volume":"277","author":"Pilch","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.034_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D","article-title":"Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin","volume":"72","author":"Chen","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.thromres.2017.05.034_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12885-015-1083-6","article-title":"Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity","volume":"15","author":"Yang","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.034_bb0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1538-7836.2005.01770.x","article-title":"Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice","volume":"4","author":"Terraube","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.034_bb0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s40064-015-1217-y","article-title":"A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients","volume":"4","author":"Weinberg","year":"2015","journal-title":"Spring"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.034_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006291607871","article-title":"Antimetastatic effect of desmopressin in a mouse mammary tumor model","volume":"57","author":"Alonso","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.034_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.10141","article-title":"Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation","volume":"81","author":"Giron","year":"2002","journal-title":"J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.034_bb0070","first-page":"5049","article-title":"Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer","volume":"30","author":"Ripoll","year":"2010","journal-title":"Anticancer Res."},{"issue":"17","key":"10.1016\/j.thromres.2017.05.034_bb0075","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199804233381701","article-title":"The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism","volume":"338","author":"Sorensen","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.05.034_bb0080","doi-asserted-by":"crossref","first-page":"I-17","DOI":"10.1161\/01.CIR.0000078466.72504.AC","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.thromres.2017.05.034_bb0085","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.165.15.1782","article-title":"Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults","volume":"165","author":"White","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.034_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-149-5-200809020-00007","article-title":"Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?","volume":"149","author":"Carrier","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.034_bb0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.chest.2016.10.025","article-title":"Development of a risk prediction score for occult cancer in patients with VTE","volume":"151","author":"Jara-Palomares","year":"2017","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.034_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1538-7836.2004.00721.x","article-title":"Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism","volume":"2","author":"Monreal","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.034_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2010.04101.x","article-title":"Is extensive screening for cancer in idiopathic venous thromboembolism warranted?","volume":"9","author":"van Doormaal","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.034_bb0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1506623","article-title":"Screening for occult cancer in unprovoked venous thromboembolism","volume":"373","author":"Carrier","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.034_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1470-2045(15)00480-5","article-title":"Limited screening with versus without (18)F-fluorodeoxyglucose PET\/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial","volume":"17","author":"Robin","year":"2016","journal-title":"Lancet Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2017.05.034_bb0120","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(16)30091-3","article-title":"Venous thromboembolism and occult cancer: impact on clinical practice","volume":"140","author":"Gheshmy","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.05.034_bb0125","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","article-title":"Venous thromboembolism and cancer","volume":"351","author":"Baron","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.thromres.2017.05.034_bb0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1055-9965.EPI-13-1138","article-title":"Venous thromboembolism and cancer risk among elderly adults in the United States","volume":"23","author":"Marks","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.thromres.2017.05.034_bb0135","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1046\/j.1538-7836.2003.00505.x","article-title":"Screening for occult cancer in patients with idiopathic venous thromboembolism: yes","volume":"1","author":"Piccioli","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.034_bb0140","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1046\/j.1538-7836.2003.00490.x","article-title":"Screening for occult cancer in patients with idiopathic venous thromboembolism: no","volume":"1","author":"Lee","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.034_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamainternmed.2016.1783","article-title":"Cancer screening after unprovoked venous thromboembolism: a teachable moment","volume":"176","author":"Khan","year":"2016","journal-title":"JAMA Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2017.05.034_bb0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-125-10-199611150-00001","article-title":"Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis","volume":"125","author":"Cornuz","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"6933","key":"10.1016\/j.thromres.2017.05.034_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.308.6933.891","article-title":"Deep venous thrombosis and occult malignancy: an epidemiological study","volume":"308","author":"Nordstrom","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2017.05.034_bb0160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/asheducation-2006.1.438","article-title":"Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms","author":"Lee","year":"2006","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.034_bb0165","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2004.00720.x","article-title":"Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial","volume":"2","author":"Piccioli","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2017.05.034_bb0170","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1538-7836.2005.01606.x","article-title":"Decision analysis for cancer screening in idiopathic venous thromboembolism","volume":"3","author":"Di Nisio","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.034_bb0175","series-title":"Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"10.1016\/j.thromres.2017.05.034_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010837.pub2","article-title":"Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE","volume":"3","author":"Robertson","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.034_bb0185","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1055\/s-0036-1592335","article-title":"Extensive computed tomography versus limited screening for detection of occult cancer in unprovoked venous thromboembolism: a multicenter, controlled, randomized clinical trial","volume":"42","author":"Prandoni","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2017.05.034_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2017.01.007","article-title":"Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism","volume":"151","author":"Coyle","year":"2017","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.034_bb0195","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdn156","article-title":"The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism","volume":"19","author":"Beckers","year":"2008","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.034_bb0200","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.28229","article-title":"Screening for occult malignancy with FDG-PET\/CT in patients with unprovoked venous thromboembolism","volume":"133","author":"Alfonso","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.034_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2011.06.025","article-title":"A pilot study utilizing whole body 18 F-FDG-PET\/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism","volume":"129","author":"Rondina","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.034_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-015-1313-4","article-title":"Guidance for the prevention and treatment of cancer-associated venous thromboembolism","volume":"41","author":"Khorana","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"16","key":"10.1016\/j.thromres.2017.05.034_bb0215","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2015-11-682963","article-title":"Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism","volume":"127","author":"Ihaddadene","year":"2016","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T07:22:29Z","timestamp":1602228149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"alternative-id":["S0049384817303547"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.034","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult cancer detection in patients with hemostatic disorder and venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}